                         SEQUENCE LISTING

<110>  IBA GmbH
 
<120>  Method of isolating a target cell

<130>  IBA14591PCT

<150>  EP14166718.8
<151>  2014-04-30

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Gly or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Gly, Lys, or Arg

<400>  1

Trp Xaa His Pro Gln Phe Xaa Xaa 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  2

Trp Arg His Pro Gln Phe Gly Gly 
1               5               


<210>  3
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  3

Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210>  4
<211>  4
<212>  PRT
<213>  artificial

<220>
<223>  synthetic peptide

<400>  4

His Pro Gln Phe 
1               


<210>  5
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Trp, Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Gly or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Gly, Lys, or Arg

<400>  5

Xaa Xaa His Pro Gln Phe Xaa Xaa 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Gly or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Gly, Lys, or Arg

<400>  6

Trp Xaa His Pro Gln Phe Xaa Xaa 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  7

Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210>  8
<211>  28
<212>  PRT
<213>  artificial

<220>
<223>  streptavidin binding peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(20)
<223>  Xaa is any amino acid and up to twelve of them may be absent

<400>  8

Trp Ser His Pro Gln Phe Glu Lys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Trp Ser His Pro Gln Phe Glu Lys 
            20                  25              


<210>  9
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  9

Trp Arg His Pro Gln Phe Gly Gly 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  10

Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210>  11
<211>  28
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  11

Trp Ser His Pro Gln Phe Glu Lys Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Trp Ser His Pro Gln Phe Glu Lys 
            20                  25              


<210>  12
<211>  24
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  12

Trp Ser His Pro Gln Phe Glu Lys Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Trp Ser His Pro Gln Phe Glu Lys 
            20                  


<210>  13
<211>  28
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin-binding peptide

<400>  13

Trp Ser His Pro Gln Phe Glu Lys Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Ser Ala Trp Ser His Pro Gln Phe Glu Lys 
            20                  25              


<210>  14
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  Myc-tag

<400>  14

Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
1               5                   10  


<210>  15
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  HA-tag

<400>  15

Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


<210>  16
<211>  11
<212>  PRT
<213>  artificial

<220>
<223>  VSV-G-tag

<400>  16

Tyr Thr Asp Ile Glu Met Asn Arg Leu Gly Lys 
1               5                   10      


<210>  17
<211>  11
<212>  PRT
<213>  artificial

<220>
<223>  HSV-tag

<400>  17

Gln Pro Glu Leu Ala Pro Glu Asp Pro Glu Asp 
1               5                   10      


<210>  18
<211>  14
<212>  PRT
<213>  artificial

<220>
<223>  V5-tag

<400>  18

Gly Lys Pro Ile Pro Asn Pro Leu Leu Gly Leu Asp Ser Thr 
1               5                   10                  


<210>  19
<211>  4
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin analog sequence positions 44 to 47

<400>  19

Val Thr Ala Arg 
1               


<210>  20
<211>  4
<212>  PRT
<213>  artificial

<220>
<223>  straptavidin analog sequence positions 44 to 47

<400>  20

Ile Gly Ala Arg 
1               


<210>  21
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  T7 epitope

<400>  21

Ala Ser Met Thr Gly Gly Gln Gln Met Gly 
1               5                   10  


